Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Michael A. Portman0
Date of Patent
August 27, 2024
0Patent Application Number
176482420
Date Filed
January 18, 2022
0Patent Citations
...
Patent Primary Examiner
Patent abstract
The present invention relates to the discovery that etanercept reduces the rate of resistance to intravenous gamma globulin (IVIG) in subjects with acute Kawasaki disease (KD). In certain embodiments, the co-administration of etanercept and IVIG more effectively treats acute KD in subjects older than 12 months than IVIG alone. In other embodiments, the co-administration of etanercept and IVIG ameliorates coronary artery dilation in high risk subjects.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.